NASDAQ: IVVDInvivyd Inc Stock Ownership - Who owns Invivyd?
Insider buying vs selling
Have Invivyd Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Timothy Edward Lee | Chief Commercial Officer | 2025-08-19 | 29,643 | $0.57 | $16.81kSell |
| Robert D. Allen Iii | Chief Scientific Officer | 2025-08-19 | 27,420 | $0.57 | $15.55kSell |
| Jill Andersen | Chief Legal Officer Secretary | 2025-08-19 | 49,402 | $0.57 | $28.01kSell |
| William E. Duke | Chief Financial Officer | 2025-08-19 | 29,643 | $0.57 | $16.81kSell |
| Julie Green | Chief Human Resources Officer | 2025-08-19 | 29,643 | $0.57 | $16.81kSell |
| Timothy Edward Lee | Chief Commercial Officer | 2025-08-18 | 20,013 | $0.65 | $13.01kSell |
| Julie Green | Chief Human Resources Officer | 2025-08-18 | 20,013 | $0.65 | $13.01kSell |
| Jill Andersen | Chief Legal Officer Secretary | 2025-08-18 | 33,352 | $0.65 | $21.68kSell |
| Robert D. Allen Iii | Chief Scientific Officer | 2025-08-18 | 18,512 | $0.65 | $12.03kSell |
| William E. Duke | Chief Financial Officer | 2025-08-18 | 20,013 | $0.65 | $13.01kSell |
IVVD insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when IVVD insiders and whales buy or sell their stock.
IVVD Shareholders
What type of owners hold Invivyd Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Tillman U. Gerngross | 12.80% | 29,831,290 | $52.80M | Insider |
| Adimab LLC | 9.30% | 21,687,906 | $38.39M | Insider |
| Mithril II LP | 4.82% | 11,241,580 | $19.90M | Insider |
| Ajay Royan | 4.82% | 11,241,580 | $19.90M | Insider |
| Mithril II GP LP | 4.82% | 11,241,580 | $19.90M | Institution |
| Marc Elia | 3.97% | 9,248,250 | $16.37M | Insider |
| Vanguard Group Inc | 2.47% | 5,762,894 | $10.20M | Institution |
| Redmile Group LLC | 1.45% | 3,390,960 | $6.00M | Insider |
| Rene Russo | 0.85% | 1,985,295 | $3.51M | Insider |
| Clive Meanwell | 0.52% | 1,201,680 | $2.13M | Insider |
IVVD vs Biotech Stocks
Invivyd Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.